It is all moving in the right direction at LiDCO Group – though you wouldn't know so from the share price, which remains marooned at 20.5p (compared with a recommendation price nearly two years ago of 27.75p). The half-time figures show a 71 per cent jump in sales and a halving of the loss – to £1.1 million. A third-party has now bought 25 of LiDCO's cardiovascular monitors to lease to UK hospitals, and sales in the UK and Europe almost doubled in the period.

  Positive signs for the future are regulatory approvals in six new countries (including Brazil, Latin America's biggest medical market) and applications in the new EU countries that are expected to bear fruit by the year-end. A £22 million market capitalisation fails utterly to reflect the potential here. Hold.

LiDCO	AIM	£10.29m	7.25p	0.00p
Click here for interactive charting
Other company articles:
LiDCO Group			03/06/2008
Healthy prospects			02/06/2008
LiDCO sees second half upturn			18/10/2006
LiDCO halves losses			10/05/2006
LiDCO raises convertible finance			09/05/2006